RANI THERAPEUTICS HOLDINGS-A (RANI) Stock Income Statement
NASDAQ:RANI - Nasdaq - US7530181004 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.20M | 1.03M | 0.00 | 0.00 | 2.72M | |||
| Minority Interest Expense | 24.74M | 26.57M | 33.91M | 32.76M | 44.76M | |||
| Operating Expenses | 48.78M | 50.63M | 66.10M | 63.45M | 54.32M | |||
| Research and Development | 25.67M | 26.68M | 39.62M | 36.61M | 26.48M | |||
| Selling, General, and Administrative Expenses | 23.11M | 23.95M | 26.48M | 26.84M | 27.83M | |||
| Operating Income | -47.58M | -49.60M | -66.10M | -63.45M | -51.60M | |||
| Interest Income/Expense | -3.25M | -3.27M | -1.78M | 180.00K | -380.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | -370.00K | |||
| Non Recurring Items | N/A | -3.71M | N/A | 0.00 | -700.00K | |||
| Income Before Taxes | -54.54M | -56.58M | -67.88M | -63.27M | -53.05M | |||
| Income Tax | N/A | 0.00 | 0.00 | 70.00K | 40.00K | |||
| Net Income | -29.80M | -30.02M | -33.97M | -30.59M | -8.33M | |||
| EBITDA | -46.55M | -48.57M | -65.28M | -62.90M | -51.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.98 | -1.05 | -1.33 | -1.28 | -0.43 | |||
| Non GAAP EPS | -0.99 | -1.06 | -1.33 | -1.28 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -2483.25% | -2920.04% | N/A | N/A | -306.25% | |||
| Operating Profit Margin | -3965.00% | -4824.90% | N/A | N/A | -1897.06% | |||
All data in USD